How can evidence-based medicine (EBM) methodology support drug withdrawals?
European Pharmaceutical Review
JULY 20, 2022
1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Study focus.
Let's personalize your content